Press

Numinus Completes Acquisition of Neurology Centre of Toronto

Sep 23 • 4 min read

Quick Take: The clinic will continue operation under the name “Neurology Centre of Toronto by Numinus”. Numinus Wellness Inc. (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced it has closed its acquisition of the Neurology Centre of Toronto (NCT), a leading Canadian provider of clinical neurologic care. The purchase…

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

Sep 22 • 4 min read

Quick Take: FSD Pharma has closed on the acquisition of Lucid Psycheceuticals, a company focused on developing psychedelic medicine for neurodegenerative diseases. FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce the completion of the previously announced acquisition…

Mindset Pharma Announces Further Preclinical Results for its 5-MeO-DMT-Inspired Drug Candidate.

Sep 20 • 2 min read

Quick Take: Mindset has announced that its preclinical trials for its DMT-inspired candidate MSP-4018 have shown strong preclinical efficacy and safety data. Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today…

Delic to Acquire Ketamine Wellness Centers Inc, Becoming Largest Psychedelic Wellness Chain in United States

Sep 20 • 7 min read

Quick Take: Delic has announced a merger with Arizona-based ketamine infusion clinic company KWC. KWC operates 10 clinics across multiple states, cementing Delic’s position as the largest ketamine health provider in the country. Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform today announced it has entered into a binding merger agreement…

Enveric Biosciences Announces Closing of MagicMed Industries Acquisition

Sep 17 • 3 min read

Quick Take: MagicMed, a privately-held biotechnology company with a focus on DMT and psilocybin, has been acquired by Enviric Enveric Biosciences (NASDAQ: ENVB), a patient-centric biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced the closing of its acquisition of MagicMed Industries Inc. (“MagicMed”), a privately-held biotechnology company focused on…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441